SHWG.F Stock Overview
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Shandong Weigao Group Medical Polymer Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.96 |
| 52 Week High | HK$1.73 |
| 52 Week Low | HK$0.96 |
| Beta | 0.45 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -42.66% |
| 5 Year Change | n/a |
| Change since IPO | -61.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHWG.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.7% |
| 1Y | n/a | -2.2% | 20.5% |
Return vs Industry: Insufficient data to determine how SHWG.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SHWG.F performed against the US Market.
Price Volatility
| SHWG.F volatility | |
|---|---|
| SHWG.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SHWG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHWG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12,333 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, specialized single-use clinical collection kits, digital products for clinical care, digestive nutrition, and primary care products; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, open and minimally invasive surgical equipment, wound healing dressings, wound suture, wound cleaning, and nonvascular catheter supporting extracorporeal devices.
Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary
| SHWG.F fundamental statistics | |
|---|---|
| Market cap | US$2.93b |
| Earnings (TTM) | US$333.83m |
| Revenue (TTM) | US$1.87b |
8.8x
P/E Ratio1.6x
P/S RatioIs SHWG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHWG.F income statement (TTM) | |
|---|---|
| Revenue | CN¥13.44b |
| Cost of Revenue | CN¥6.50b |
| Gross Profit | CN¥6.94b |
| Other Expenses | CN¥4.54b |
| Earnings | CN¥2.40b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 26, 2024
| Earnings per share (EPS) | 0.52 |
| Gross Margin | 51.62% |
| Net Profit Margin | 17.85% |
| Debt/Equity Ratio | 17.8% |
How did SHWG.F perform over the long term?
See historical performance and comparison